Chong J, Ji F, Hilal S, Chong J, Lau J, Tong N
Alzheimers Dement. 2024; 20(12):8739-8757.
PMID: 39537356
PMC: 11667494.
DOI: 10.1002/alz.14328.
Jang H, Shin D, Kim Y, Kim K, Lee J, Kim J
Dement Neurocogn Disord. 2024; 23(4):212-223.
PMID: 39512701
PMC: 11538854.
DOI: 10.12779/dnd.2024.23.4.212.
Li T, Li B, Xu X, Zhong J, Wang T, Liu F
Front Aging Neurosci. 2024; 16:1412735.
PMID: 39328245
PMC: 11425965.
DOI: 10.3389/fnagi.2024.1412735.
Kooshki A, Farmani R, Mehrpour O, Naghizadeh A, Amirabadizadeh A, Kavoosi S
Biol Trace Elem Res. 2024; .
PMID: 39080233
DOI: 10.1007/s12011-024-04326-x.
Leow Y, Soo S, Kumar D, Binte Zailan F, Sandhu G, Vipin A
J Alzheimers Dis. 2024; 97(4):1727-1735.
PMID: 38306040
PMC: 10894567.
DOI: 10.3233/JAD-230898.
Contributions of amyloid beta and cerebral small vessel disease in clinical decline.
Moonen J, Haan R, Bos I, Teunissen C, van de Giessen E, Tomassen J
Alzheimers Dement. 2023; 20(3):1868-1880.
PMID: 38146222
PMC: 10984432.
DOI: 10.1002/alz.13607.
Editorial: Additive or synergistic impacts of sleep, circadian rhythm disturbances and other modifiable risk factors on established and novel plasma biomarkers of Alzheimer's disease pathology.
Bubu O, Kam K, Parekh A, Ayappa I
Front Aging Neurosci. 2023; 15:1168062.
PMID: 36998316
PMC: 10043465.
DOI: 10.3389/fnagi.2023.1168062.
Amyloid-PET and White Matter Hyperintensities Have Independent Effects on Baseline Cognitive Function and Synergistic Effects on Longitudinal Executive Function.
Ali D, Abner E, Bahrani A, El Khouli R, Gold B, Jiang Y
Brain Sci. 2023; 13(2).
PMID: 36831761
PMC: 9953773.
DOI: 10.3390/brainsci13020218.
Interaction between Alzheimer's Disease and Cerebral Small Vessel Disease: A Review Focused on Neuroimaging Markers.
Kim S, Kim H, Jang H, Weiner M, DeCarli C, Na D
Int J Mol Sci. 2022; 23(18).
PMID: 36142419
PMC: 9499680.
DOI: 10.3390/ijms231810490.
The Clustering Analysis of Time Properties in Patients With Cerebral Small Vessel Disease: A Dynamic Connectivity Study.
Yin W, Zhou X, Li C, You M, Wan K, Zhang W
Front Neurol. 2022; 13:913241.
PMID: 35795790
PMC: 9251301.
DOI: 10.3389/fneur.2022.913241.
Performance of the plasma Aβ42/Aβ40 ratio, measured with a novel HPLC-MS/MS method, as a biomarker of amyloid PET status in a DPUK-KOREAN cohort.
Jang H, Kim J, Lee H, Kim C, Na D, Kim H
Alzheimers Res Ther. 2021; 13(1):179.
PMID: 34686209
PMC: 8540152.
DOI: 10.1186/s13195-021-00911-7.
White matter network damage mediates association between cerebrovascular disease and cognition.
Hilal S, Liu S, Wong T, Vrooman H, Cheng C, Venketasubramanian N
J Cereb Blood Flow Metab. 2021; 41(8):1858-1872.
PMID: 33530830
PMC: 8327109.
DOI: 10.1177/0271678X21990980.
Concordance in detecting amyloid positivity between F-florbetaben and F-flutemetamol amyloid PET using quantitative and qualitative assessments.
Cho S, Choe Y, Kim Y, Lee B, Kim H, Jang H
Sci Rep. 2020; 10(1):19576.
PMID: 33177593
PMC: 7658982.
DOI: 10.1038/s41598-020-76102-5.
Prediction of amyloid β PET positivity using machine learning in patients with suspected cerebral amyloid angiopathy markers.
Jung Y, Lee H, Kim H, Na D, Han H, Jang H
Sci Rep. 2020; 10(1):18806.
PMID: 33139780
PMC: 7608617.
DOI: 10.1038/s41598-020-75664-8.
Head-to-Head Comparison of 18F-Florbetaben and 18F-Flutemetamol in the Cortical and Striatal Regions.
Cho S, Choe Y, Kim Y, Kim H, Jang H, Kim Y
J Alzheimers Dis. 2020; 76(1):281-290.
PMID: 32474468
PMC: 9711935.
DOI: 10.3233/JAD-200079.
An Assessment of the Relationship between Structural and Functional Imaging of Cerebrovascular Disease and Cognition-Related Fibers.
Tang X, Xiao X, Yin J, Yang T, Zeng B
Comput Math Methods Med. 2020; 2020:4347676.
PMID: 32411283
PMC: 7201792.
DOI: 10.1155/2020/4347676.
Characteristic Biomarker and Cognitive Profile in Incipient Mixed Dementia.
Eckerstrom C, Eckerstrom M, Gothlin M, Molinder A, Jonsson M, Kettunen P
J Alzheimers Dis. 2019; 73(2):597-607.
PMID: 31815692
PMC: 7029359.
DOI: 10.3233/JAD-190651.
Application of an amyloid and tau classification system in subcortical vascular cognitive impairment patients.
Jang H, Kim H, Park S, Park Y, Choe Y, Cho H
Eur J Nucl Med Mol Imaging. 2019; 47(2):292-303.
PMID: 31471715
DOI: 10.1007/s00259-019-04498-y.
Clinical significance of amyloid β positivity in patients with probable cerebral amyloid angiopathy markers.
Jang H, Jang Y, Kim H, Werring D, Lee J, Choe Y
Eur J Nucl Med Mol Imaging. 2019; 46(6):1287-1298.
PMID: 30937462
DOI: 10.1007/s00259-019-04314-7.
Cognitive Effects of White Matter Pathology in Normal and Pathological Aging.
Kaskikallio A, Karrasch M, Rinne J, Tuokkola T, Parkkola R, Gronholm-Nyman P
J Alzheimers Dis. 2018; 67(2):489-493.
PMID: 30594927
PMC: 6484248.
DOI: 10.3233/JAD-180554.